Effettuare il login Iscriviti gratis

Navidea Biopharmaceuticals Inc Ret. sull'asset

Cos'è Ret. sull'asset di Navidea Biopharmaceuticals Inc?

Ret. sull'asset di Navidea Biopharmaceuticals Inc è -87.38%

Qual è la definizione di Ret. sull'asset?



Il rendimento delle attività indica quanto redditizie le attività di un'azienda stanno generando entrate. Viene calcolato dividendo il reddito netto per il patrimonio medio totale.

The return on assets (ROA) tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control. It's a useful number for comparing competing companies in the same industry. The number will vary widely across different industries. Return on assets gives an indication of the capital intensity of the company, which will depend on the industry; companies that require large initial investments will generally have lower return on assets. ROAs over 5% are generally considered good.

Ret. sull'asset di aziende nel Health Care settore su NYSEMKT rispetto a Navidea Biopharmaceuticals Inc

Cosa fa Navidea Biopharmaceuticals Inc?

navidea biopharmaceuticals, inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. it operates through two segments, diagnostic substances and therapeutic development programs. the company develops manocept platform to target the cd206 mannose receptor expressed on activated macrophages. its cd206-targeted drug platform is applicable to a range of diagnostic modalities, including single photon emission computed tomography, positron emission tomography (pet), imaging and topical gamma-scanning, and intra-operative and/or optical-fluorescence detection, as well as delivery of therapeutic compounds that target macrophages, and immune-and inflammation-involved diseases. further, the company offers nav4694, a fluorine-18 labeled pet imaging agent for use as an aid in the imaging and evaluation of patients with signs or symptoms of alzheimer's disease and mild cognitive impairment. in addition, it is de

Aziende con ret. sull'asset simili a Navidea Biopharmaceuticals Inc